| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 09/11/2013 | CN101743006B Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 09/11/2013 | CN101151255B 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 09/10/2013 | US8530667 Herbicides |
| 09/10/2013 | US8530655 HIV replication inhibiting pyrimidines |
| 09/10/2013 | US8530654 Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid |
| 09/10/2013 | US8530653 Enzyme inhibiting compounds |
| 09/10/2013 | US8530490 Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 09/10/2013 | US8530487 Compounds useful for treating disorders related to TRPA1 |
| 09/10/2013 | US8530483 Substituted azabenzoxazoles |
| 09/10/2013 | US8530472 Ethynyl derivatives |
| 09/10/2013 | US8530461 Azetidine derivatives |
| 09/10/2013 | US8530460 Azetidine derivatives |
| 09/05/2013 | US20130231479 Aryloxyurea compound and pest control agent |
| 09/05/2013 | US20130231356 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 09/05/2013 | US20130231342 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 09/05/2013 | US20130231336 Substituted pyrimidinyl-amines as protein kinase inhibitors |
| 09/04/2013 | EP2634178A1 Quinazoline derivative and quinazoline complex protein kinase inhibitor for inhibiting multiplication of tumor cells and preparation method thereof |
| 09/04/2013 | EP2634175A1 Substituted 4-amino-picolinic acids and their use as herbicides |
| 09/04/2013 | EP2632903A2 Metalloenzyme inhibitor compounds |
| 09/04/2013 | EP2632902A2 Improved oral targetted drug delivery system |
| 09/04/2013 | CN103275067A Inhibitors of histone deacetylase |
| 09/04/2013 | CN103275020A Erlotinib preparation method |
| 09/04/2013 | CN103275019A 4-(3-chloro-4-substituted anilino)-6-substituted methoxyl carbamonyl quinazoline compounds, and a preparation method and applications thereof |
| 09/04/2013 | CN103275018A 4-(3-chloro-4-substituted anilino)-6-substituted carbamonyl quinazoline compounds, and preparation method and applications thereof |
| 09/04/2013 | CN103275017A 2-substituted quinazolinone compound, its synthesis method and application |
| 09/04/2013 | CN103275016A Synthetic method of 2-subsituted quinazoline compounds |
| 09/04/2013 | CN103275015A Bisphenol monomer containing bipyridine structure, as well as preparation method and application thereof |
| 09/04/2013 | CN102153433B N-monosubstituted-alpha-carbonylamide compound and preparation method thereof |
| 09/03/2013 | US8524724 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 09/03/2013 | US8524722 Substituted tricyclic compounds and methods of use thereof |
| 09/03/2013 | US8524721 Platelet ADP receptor inhibitors |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 08/29/2013 | WO2013124791A1 Solid form of bosentan |
| 08/29/2013 | US20130225815 Fluoroalkylation Methods And Reagents |
| 08/29/2013 | US20130225814 Optically active dibenzylamine derivative, and method for preparing thereof |
| 08/29/2013 | US20130225622 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt |
| 08/29/2013 | US20130225619 Substituted heterocyclic compounds for disease treatment |
| 08/29/2013 | US20130225613 Quinazoline derivatives and pharmaceutical compositions thereof |
| 08/29/2013 | US20130225611 Compositions and Methods for Reducing Cancer Cell Proliferation and Modulating Importin-Beta Function |
| 08/29/2013 | US20130225610 Antimetastatic compounds |
| 08/29/2013 | US20130225596 Novel heterocyclic derivative and pharmaceutical composition comprising the same (as amended) |
| 08/29/2013 | US20130224152 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections |
| 08/29/2013 | US20130224149 Process for preparing antiviral compounds |
| 08/29/2013 | DE102012101673A1 Salze eines Dihydrochinazolinderivats Salts of Dihydrochinazolinderivats |
| 08/29/2013 | DE102012101659A1 Salze eines Dihydrochinazolinderivats Salts of Dihydrochinazolinderivats |
| 08/28/2013 | EP2630122A1 Arylamide derivatives as ttx-s blockers |
| 08/28/2013 | CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 08/28/2013 | CN103270026A Bi-heteroaryl compounds as vps34 inhibitors |
| 08/28/2013 | CN103270025A Method for preparing rosuvastatin salts |
| 08/28/2013 | CN103269588A Arthropod pest control composition and method for controlling arthropod pests |
| 08/28/2013 | CN103265497A Intermediate compound 4-chloro-6-amino-7-hydroxyquinazoline required for synthesis of tinib antineoplastic drug and preparation method thereof |
| 08/28/2013 | CN103265496A Preparation method of azoxystrobin |
| 08/28/2013 | CN103265495A Multicyclic amino acid derivatives and methods of their use |
| 08/28/2013 | CN102952086B Preparation method of 2-morpholinyl-substituted pyrimidine compounds |
| 08/28/2013 | CN102234249B N-(hexahydropyrimidine-1,3-diyl)-di-L-amino acid methyl ester, preparation method thereof and application thereof |
| 08/28/2013 | CN101935317B Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof |
| 08/28/2013 | CN101535276B Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors |
| 08/27/2013 | US8518959 Quinoxaline derivatives as antitumor agents |
| 08/27/2013 | US8518955 Fused pyrimidineone compounds as TRPV3 modulators |
| 08/22/2013 | WO2013123401A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv) |
| 08/22/2013 | WO2013123240A1 Methods and compounds useful in the synthesis of orexin-2 receptor antagonists |
| 08/22/2013 | WO2013123138A2 Spiro [2.4]heptanes for treatment of flaviviridae infections |
| 08/22/2013 | WO2013120852A1 Intermediates for a novel process of preparing imatinib and related tyrosine kinase inhibitors |
| 08/22/2013 | WO2013062966A3 Methanol derivatives as trpv3 modulators |
| 08/22/2013 | US20130217876 Phosphine ligands for catalytic reactions |
| 08/22/2013 | US20130217693 Compounds and method for treatment of hiv |
| 08/22/2013 | US20130217688 Heteroaryl compounds and uses thereof |
| 08/22/2013 | US20130217661 Quinazoline derivatives |
| 08/22/2013 | US20130217660 Novel prolylcarboxypeptidase inhibitors |
| 08/22/2013 | US20130217632 Non-Natural Amino Acids |
| 08/21/2013 | EP2628732A1 Novel crystalline form of rilpivirine hydrochloride |
| 08/21/2013 | EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders |
| 08/21/2013 | EP2628011A1 Ipp complex as marker for erlotinib treatment |
| 08/21/2013 | EP2627640A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 08/21/2013 | EP2627178A1 Quinazolinone-type compounds as crth2 antagonists |
| 08/21/2013 | CN103261894A IPP complex as marker for erlotinib treatment |
| 08/21/2013 | CN103261173A Method for preparation of 2-ethyl-4-amtno-5-cyanopyrimidine |
| 08/21/2013 | CN103261172A Electronic device including a pyrimidine compound |
| 08/21/2013 | CN103261171A Bispyrimidines for electronic applications |
| 08/21/2013 | CN103261168A Neprilysin inhibitors |
| 08/21/2013 | CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators |
| 08/21/2013 | CN103261164A Neprilysin inhibitors |
| 08/21/2013 | CN103260408A Arthropod pest control composition and method for controlling arthropod pests |
| 08/21/2013 | CN103260407A Arthropod pest control composition and method for controlling arthropod pests |
| 08/21/2013 | CN103254143A 4-[4-(2-diethylamino acetamido)phenylamino]-6-(substituted methoxyl)formylamino quinazoline compound as well as preparation method and application thereof |
| 08/21/2013 | CN103254142A 4-[4-(2-subtituted amino acetylamino)phenylamino] quinazoline derivative as well as preparation method and application thereof |
| 08/21/2013 | CN103254141A 4-[4-(2-dipropylamino acetamido) phenylamino]-6-substituted quinazoline compound as well as preparation method and application thereof |
| 08/21/2013 | CN103254140A Novel <18>F marked substituted quinazoline compound, and preparation method and tumor PET development application thereof |
| 08/21/2013 | CN103254139A Novel <18>F marked 4-aminoquinazoline derivatives, and preparation methods and tumor PET development application thereof |
| 08/21/2013 | CN103254138A Process for preparing N-substituted hydroxypyrimidinone carboxamides |
| 08/21/2013 | CN103254137A 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and use thereof as herbicides |
| 08/21/2013 | CN102127056B Tubulin inhibitors |
| 08/21/2013 | CN101899010B Quinazol derivative, preparation method and application thereof |
| 08/21/2013 | CN101790517B Inhibitor of binding of s1p1 |
| 08/21/2013 | CN101429166B Quinazoline ketone derivant, preparation method and application thereof |
| 08/20/2013 | US8513436 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| 08/20/2013 | US8513413 Process for the preparation of nitroorotic acid |
| 08/20/2013 | US8513412 Rosuvastatin and atorvastatin derivatives |
| 08/20/2013 | US8513270 Substituted heterocycles as Janus kinase inhibitors |
| 08/20/2013 | US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy |